Lab No. : TLG/04-06-2024/SR9196543 Lab Add.

: Newtown,Kolkata-700156

Patient Name : RAMAKANT MISHRA Ref Dr. : Dr.MEDICAL OFFICER

Age : 53 Y 3 M 17 D Collection Date : 06/Jun/2024 11:24AM

Gender :M Report Date : 06/Jun/2024 02:59PM

DEPARTMENT OF BIOCHEMISTRY
Test Name Result Bio Ref. Interval Unit

GLUCOSE,FASTING , BLOOD, NAF PLASMA 98 Impaired Fasting-100-125 . mg/dL

(Method:Gluc Oxidase Trinder) Diabetes- >= 126.
Fasting is defined as no caloric intake
for at least 8 hours.

In the absence of unequivocal hyperglycemia, diagnosis requires two abnormal test results from the same sample or in two separate test samples.

Reference :
ADA Standards of Medical Care in Diabetes – 2020. Diabetes Care Volume 43, Supplement 1.

LIVER FUNCTION TEST , GEL SERUM

BILIRUBIN (TOTAL) 0.90 0.3-1.2 mg/dL
(Method:Vanadate oxidation)
BILIRUBIN (DIRECT) 0.10 <0.2 mg/dL
(Method:Vanadate oxidation)
BILIRUBIN (INDIRECT) 0.8 0.0 - 0.9 mg/dl
(Method:Calculated)
SGPT/ALT 22 7-40 U/L
(Method:Modified IFCC)
SGOT/AST 26 13-40 U/L
(Method:Modified IFCC)
ALKALINE PHOSPHATASE 90 46-116 U/L
(Method:IFCC standardization )
TOTAL PROTEIN 7.10 5.7-8.2 g/dL g/dL
(Method:BIURET METHOD)
ALBUMIN,BLOOD 4.30 3.2-4.8 g/dL
(Method:BCG Dye Binding)
GLOBULIN 2.80 1.8-3.2 g/dl
(Method:Calculated)
AG Ratio 1.54 1.0 - 2.5
(Method:Calculated)

*** End Of Report ***

Page 1 of 11
 Lab No. : TLG/04-06-2024/SR9196543 Lab Add. : Newtown,Kolkata-700156

Patient Name : RAMAKANT MISHRA Ref Dr. : Dr.MEDICAL OFFICER

Age : 53 Y 3 M 17 D Collection Date : 06/Jun/2024 11:24AM

Gender :M Report Date : 06/Jun/2024 03:00PM

DEPARTMENT OF BIOCHEMISTRY
Test Name Result Bio Ref. Interval Unit

POTASSIUM,BLOOD 4.40 3.5-5.5 mEq/L

(Method:ISE INDIRECT)

LIPASE,BLOOD 28 12-53 U/L U/L

(Method:Colorimetric Rate)

GAMMA GT (GGTP) 19.00 < 73 U/L U/L

(Method:Modified IFCC(Nitroanilide))

URIC ACID,BLOOD 6.50 3.5-7.2 mg/dL

(Method:Uricase/Peroxidase)

SODIUM,BLOOD 137 132 - 146 mEq/L

(Method:ISE INDIRECT)

25-HYDROXY VITAMIN D - TOTAL 25.62 ***FOR BIOLOGICAL REFERENCE ng/mL

(Method:CLIA) INTERVAL DETAILS , PLEASE
REFER TO THE BELOW
MENTIONED REMARKS/NOTE
WITH ADDITIONAL CLINICAL
INFORMATION ***

Biological Reference Intervals :

<20 ng/mL (deficiency)*
20-30 ng/mL (insufficient)**
30-100 ng/mL (optimum levels)***
>100 ng/mL (toxicity possible)****

* Could be associated with osteomalacia/ rickets

** May be associated with increased risk of osteoporosis or secondary hyperparathyroidism
*** Optimum levels in the normal population
**** 80 ng/mL is the lowest reported level associated with toxicity in patients without primary hyperparathyroidism who have normal renal function. Most
patients with toxicity have levels >150 ng/mL. Patients with renal failure can have very high 25-OH-VitD levels without any signs of toxicity, as renal
conversion to the active hormone 1,25-OH-VitD is impaired or absent.
These reference ranges represent clinical decision values that apply to males and females of all ages, rather than population-based reference values.
Population reference ranges for 25-OH-VitD vary widely depending on ethnic background, age, geographic location of the studied populations, and the
sampling-season. Population-based ranges correlate poorly with serum 25-OH-VitD concentrations that are associated with biologically and clinically
relevant vitamin D effects and are therefore of limited clinical value.

Clinical References :
1.Holick MF. Vitamin D Deficiency. N Engl J Med. 2007;357:266-81.
2. Jones G, Strugnell SA, DeLuca HF: Current understanding of the molecular actions of vitamin D. Physiol Rev 1998 Oct;78(4):1193-1231.
3. Miller WL, Portale AA: Genetic causes of rickets. Curr Opin Pediatr 1999 Aug;11(4):333-339
4. Vieth R: Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999 May;69(5):842-856.

AMYLASE,BLOOD 65.0 30 - 118 U/L

(Method:Ethylidene Blocked-pNPG7)

TSH (THYROID STIMULATING HORMONE) 1.590 0.55-4.78 µIU/mL

(Method:CLIA)

Serum TSH levels exhibit a diurnal variation with the peak occurring during the night and the nadir, which approximates to 50% of the peak value, occurring
Lab No. : TLG/04-06-2024/SR9196543 Page 2 of 11
 Lab No. : TLG/04-06-2024/SR9196543 Lab Add. : Newtown,Kolkata-700156

Patient Name : RAMAKANT MISHRA Ref Dr. : Dr.MEDICAL OFFICER

Age : 53 Y 3 M 17 D Collection Date : 06/Jun/2024 11:24AM

Gender :M Report Date : 06/Jun/2024 03:00PM

DEPARTMENT OF BIOCHEMISTRY
Test Name Result Bio Ref. Interval Unit

between 1000 and 1600 hours.[1,2]

References:
1. Bugalho MJ, Domingues RS, Pinto AC, Garrao A, Catarino AL, Ferreira T, Limbert E and Sobrinho L. Detection of thyroglobulin mRNA transcripts in
peripheral blood of
individuals with and without thyroid glands: evidence for thyroglobulin expression by blood cells. Eur J Endocrinol 2001;145:409-13.
2. Bellantone R, Lombardi CP, Bossola M, Ferrante A,Princi P, Boscherini M et al. Validity of thyroglobulin mRNA assay in peripheral blood of
postoperative thyroid carcinoma patients in predicting tumor recurrence varies according to the histologic type: results of a prospective study. Cancer
2001;92:2273-9.

BIOLOGICAL REFERENCE INTERVAL: [ONLY FOR PREGNANT MOTHERS]

Trimester specific TSH LEVELS during pregnancy:
FIRST TRIMESTER: 0.10 – 3.00 µ IU/mL
SECOND TRIMESTER: 0.20 -3.50 µ IU/mL
THIRD TRIMESTER : 0.30 -3.50 µ IU/mL
References:
1. Erik K. Alexander, Elizabeth N. Pearce, Gregory A. Brent, Rosalind S. Brown, Herbert Chen, Chrysoula Dosiou, William A. Grobman, Peter
Laurberg, John H. Lazarus, Susan J. Mandel, Robin P. Peeters, and Scott Sullivan.Thyroid.Mar 2017.315-389.http://doi.org/10.1089/thy.2016.0457
2. Kalra S, Agarwal S, Aggarwal R, Ranabir S. Trimester-specific thyroid-stimulating hormone: An indian perspective. Indian J Endocr Metab
2018;22:1-4.

FREE T4 (FREE THYROXINE) 1.140 0.89-1.76 ng/dl

(Method:CLIA) ~In pregnancy:
~FIRST TRIMESTER: 0.92 – 1.51
~SECOND TRIMESTER: 0.82 -1.37
~THIRD TRIMESTER : 0.71 -1.30

*** End Of Report ***

Lab No. : TLG/04-06-2024/SR9196543 Page 3 of 11

 Lab No. : TLG/04-06-2024/SR9196543 Lab Add. : Newtown,Kolkata-700156

Patient Name : RAMAKANT MISHRA Ref Dr. : Dr.MEDICAL OFFICER

Age : 53 Y 3 M 17 D Collection Date : 06/Jun/2024 11:24AM

Gender :M Report Date : 06/Jun/2024 02:52PM

DEPARTMENT OF BIOCHEMISTRY
Test Name Result Bio Ref. Interval Unit

CRP-C REACTIVE PROTEIN < 0.4 <1 mg/dL

(Method:Immunoturbidimetry)

LIPID PROFILE , GEL SERUM

CHOLESTEROL-TOTAL 170 Desirable: < 200 mg/dL mg/dL
(Method:Enzymatic) Borderline high: 200-239 mg/dL
High: > or =240 mg/dL
TRIGLYCERIDES 218 Normal:: < 150, mg/dL
(Method:GPO-Trinder) BorderlineHigh::150-199,
High:: 200-499,
VeryHigh::>500
HDL CHOLESTEROL 25 < 40 - Low mg/dl
(Method:Elimination/catalase) 40-59- Optimum
60 - High
LDL CHOLESTEROL DIRECT 102 OPTIMAL : <100 mg/dL, mg/dL
(Method:Elimination / Catalase) Near optimal/ above optimal : 100-
129 mg/dL,
Borderline high : 130-159 mg/dL,
High : 160-189 mg/dL,
Very high : >=190 mg/dL
VLDL 43 < 40 mg/dl mg/dl
(Method:Calculated)
CHOL HDL Ratio 6.8 LOW RISK 3.3-4.4 AVERAGE RISK
(Method:Calculated) 4.47-7.1 MODERATE RISK 7.1-11.0
HIGH RISK >11.0

Reference: National Cholesterol Education Program. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert
Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. May 16 2001;285(19):2486-97.

*** End Of Report ***

Lab No. : TLG/04-06-2024/SR9196543 Page 4 of 11

 Lab No. : TLG/04-06-2024/SR9196543 Lab Add. : Newtown,Kolkata-700156

Patient Name : RAMAKANT MISHRA Ref Dr. : Dr.MEDICAL OFFICER

Age : 53 Y 3 M 17 D Collection Date : 06/Jun/2024 11:24AM

Gender :M Report Date : 06/Jun/2024 03:53PM

DEPARTMENT OF HAEMATOLOGY
Test Name Result Bio Ref. Interval Unit

CBC WITH PLATELET (THROMBOCYTE) COUNT , EDTA WHOLE BLOOD

HEMOGLOBIN 14.0 13 - 17 g/dL
(Method:PHOTOMETRIC)
WBC 4.8 4 - 10 *10^3/µL
(Method:DC detection method)
RBC 4.06 4.5 - 5.5 *10^6/µL
(Method:DC detection method)
PLATELET (THROMBOCYTE) COUNT 159 150 - 450*10^3 *10^3/µL
(Method:DC detection method/Microscopy)
DIFFERENTIAL COUNT
NEUTROPHILS 54 40 - 80 % %
(Method:Flowcytometry/Microscopy)
LYMPHOCYTES 30 20 - 40 % %
(Method:Flowcytometry/Microscopy)
MONOCYTES 09 2 - 10 % %
(Method:Flowcytometry/Microscopy)
EOSINOPHILS 07 1-6% %
(Method:Flowcytometry/Microscopy)
BASOPHILS 00 0-0.9% %
(Method:Flowcytometry/Microscopy)
CBC SUBGROUP
HEMATOCRIT / PCV 43.6 40 - 50 % %
(Method:Calculated)
MCV 107.3 83 - 101 fl fl
(Method:Calculated)
MCH 34.3 27 - 32 pg pg
(Method:Calculated)
MCHC 32.0 31.5-34.5 gm/dl gm/dl
(Method:Calculated)
RDW - RED CELL DISTRIBUTION WIDTH 16.3 11.6-14% %
(Method:Calculated)
PDW-PLATELET DISTRIBUTION WIDTH 37.5 8.3 - 25 fL fL
(Method:Calculated)
MPV-MEAN PLATELET VOLUME 14.4 7.5 - 11.5 fl
(Method:Calculated)

ESR (ERYTHROCYTE SEDIMENTATION RATE) , EDTA WHOLE BLOOD

1stHour 18 0.00 - 20.00 mm/hr mm/hr
(Method:Westergren)

*** End Of Report ***

Lab No. : TLG/04-06-2024/SR9196543 Page 5 of 11

 Lab No. : TLG/04-06-2024/SR9196543 Lab Add. : Tollygunge

Patient Name : RAMAKANT MISHRA Ref Dr. : Dr.MEDICAL OFFICER

Age : 53 Y 3 M 17 D Collection Date :

Gender :M Report Date : 05/Jun/2024 04:36PM

DEPARTMENT OF CARDIOLOGY
E.C.G. REPORT

DATA
HEART RATE 88 Bpm

PR INTERVAL 144 Ms

QRS DURATION 73 Ms

QT INTERVAL 362 Ms

QTC INTERVAL 439 Ms

AXIS
P WAVE 54 Degree

QRS WAVE 10 Degree

T WAVE 15 Degree

IMPRESSION sinus rhythm

:

*** End Of Report ***

Lab No. : TLG/04-06-2024/SR9196543 Page 6 of 11

 Lab No. : TLG/04-06-2024/SR9196543 Lab Add. : Tollygunge

Patient Name : RAMAKANT MISHRA Ref Dr. : Dr.MEDICAL OFFICER

Age : 53 Y 3 M 17 D Collection Date :

Gender :M Report Date : 05/Jun/2024 04:42PM

DEPARTMENT OF CARDIOLOGY
ECHO CARDIOGRAPHY- 2D

M MODE DATA :

PARAMETER TEST VALUE NORMAL RANGE

Aortic root diameter 3.01 2.0 - 4.0 cm
Left atrial diameter 3.53 2.0 - 4.0 cm
RV internal diameter 1.49 0.6 - 2.3 cm
IV septal thickness (diastole) 0.98 0.60 - 1.10 cm
LV internal diameter (diastole) 4.32 3.50 - 5.60 cm
Post wall thickness (diastole) 1.01 0.60 - 1.10 cm
LV internal diameter (systole) 2.84 2.40 - 4.20 cm
LV Ejection fraction 64% 55 - 75%

OBSERVATION :

1) Left Ventricle:

Cavity size / wall thickness : within normal limits.

LV wall motion study : No regional wall motion abnormality.

Systolic function : Good.

Diastolic compliance : Reduced (Impaired relaxation. E/e’ – 9.1 cm/s).

2) Left Atrium :

Normal size, no mass in the appendage / body.

3) Right Ventricle and Right Atrium :

Normal size, good RV systolic function. TAPSE = 23 mm

4) Mitral Valve :

Normal leaflets, good excursion, normal subvalvar apparatus.

No significant regurgitation.

5) Aortic Valve :

Three cusps- no thickening, good systolic excursion.

No significant regurgitation noted.

Lab No. : TLG/04-06-2024/SR9196543 Page 7 of 11
 Lab No. : TLG/04-06-2024/SR9196543 Lab Add. : Tollygunge

Patient Name : RAMAKANT MISHRA Ref Dr. : Dr.MEDICAL OFFICER

Age : 53 Y 3 M 17 D Collection Date :

Gender :M Report Date : 05/Jun/2024 04:42PM

DEPARTMENT OF CARDIOLOGY

6) Tricuspid Valve :

Normal leaflets, normal sized annulus, mild regurgitation.

7) Pulmonary Valve :

Normal cusps, good systolic excursion.

8) Ventricular Septum :

Intact.

9) Inter atrial septum :

Intact.

10) Pericardium :

No thickening, no effusion.

11) Others :

No intra-cardiac mass.

Estimated PA pressure : 30 mm Hg (Systolic).

IMPRESSION :

Good left ventricular systolic function. (LVEF 64 %)

Reduced diastolic compliance.
No pulmonary arterial hypertension.

Please correlate clinically.

*** End Of Report ***

Lab No. : TLG/04-06-2024/SR9196543 Page 8 of 11

Lab No. : TLG/04-06-2024/SR9196543 Lab Add. : Tollygunge

Patient Name : RAMAKANT MISHRA Ref Dr. : Dr.MEDICAL OFFICER

Age : 53 Y 3 M 17 D Collection Date :

Gender :M Report Date : 05/Jun/2024 04:42PM

DEPARTMENT OF CARDIOLOGY

Lab No. : TLG/04-06-2024/SR9196543 Page 9 of 11

 Lab No. : TLG/04-06-2024/SR9196543 Lab Add. : Tollygunge

Patient Name : RAMAKANT MISHRA Ref Dr. : Dr.MEDICAL OFFICER

Age : 53 Y 3 M 17 D Collection Date :

Gender :M Report Date : 06/Jun/2024 02:52PM

DEPARTMENT OF ULTRASONOGRAPHY
DEPARTMENT OF ULTRASONOGRAPHY

REPORT ON EXAMINATION OF WHOLE ABDOMEN

LIVER

Liver is normal in size (12.7 cm) having normal shape, regular smooth outline. Parenchymal echogenicity of both lobes
are normal. Intrahepatic biliary radicles are not dilated. Branches of portal veins and hepatic veins are normal.

PORTA

The appearance of porta is normal. Common bile duct is (0.4 cm) in diameter, with no intraluminal pathology
(Calculi/mass) could be detected at its visualised part. Portal vein is (1.0 cm ) normal in diameter at porta.

GALL BLADDER

Gall bladder is normal in size, shape. No intraluminal calculus or mass is seen. Gall bladder wall is normal in thickness.
No pericholecystic fluid collection noted.

PANCREAS

Pancreas is normal in size, shape and contour. Parenchymal echogenecity is normal and homogeneous. No focal mass or
calcification seen. No Calcular disease noted. Pancreatic duct is not dilated. No peri-pancreatic collection of fluid noted.

SPLEEN

Spleen is normal in size (9.6 cm). Homogenous and smooth echotexture without any focal lesion. Splenic vein at hilum
appears normal. No definite collaterals could be detected.

KIDNEYS
Both kidneys are normal in shape, size (Rt. kidney 9.9 cm. & Lt. kidney 10.0 cm) axes & position. Cortical echogenicity
appears normal maintaining corticomedullary differentiation. Margin is regular and cortical thickness is uniform. No
calcular disease noted. No hydronephrotic changes detected.

URETER

Ureters are not dilated

Lab No. : TLG/04-06-2024/SR9196543 Page 10 of 11

 Lab No. : TLG/04-06-2024/SR9196543 Lab Add. : Tollygunge

Patient Name : RAMAKANT MISHRA Ref Dr. : Dr.MEDICAL OFFICER

Age : 53 Y 3 M 17 D Collection Date :

Gender :M Report Date : 06/Jun/2024 02:52PM

DEPARTMENT OF ULTRASONOGRAPHY
URINARY BLADDER

Urinary bladder is distended. Wall thickness appeared normal. No intraluminal pathology (calculi / mass) could be
detected.

PROSTATE

Prostate is normal in size. Echotexture appears within normal limits. No focal alteration of its echogenecity could be
detectable.

It measures : 5.0 x 3.3 x 2.5 cm

Approximate weight could be around = 22 gms.

IMPRESSION:

No significant abnormality detected.

**** Suggested clinical correlation and further needful investigations.

Kindly note

Ø Ultrasound is not the modality of choice to rule out subtle bowel lesion.
Ø Please Intimate us for any typing mistakes and send the report for correction within 7 days.
Ø The science of Radiological diagnosis is based on the interpretation of various shadows produced by both the normal and abnormal tissues and are not always conclusive. Further biochemical and radiological investigation & clinical
correlation is required to enable the clinician to reach the final diagnosis.

The report and films are not valid for medico-legal purpose.
Patient Identity not verified.

Lab No. : TLG/04-06-2024/SR9196543 Page 11 of 11